Strahlentherapie Und Onkologie : Organ Der Deutschen Röntgengesellschaft ... [et Al]
Overview
Strahlentherapie und Onkologie is a renowned journal that serves as the official publication of the German Roentgen Society and other esteemed organizations. It focuses on the latest advancements in radiation therapy and oncology, providing a platform for researchers, clinicians, and scientists to share their findings and insights. This journal is a valuable resource for professionals in the field, offering comprehensive coverage of innovative techniques, clinical studies, and multidisciplinary approaches to cancer treatment.
Details
Details
Metrics
Metrics
h-index / Ranks: 4506
78
SJR / Ranks: 4434
907
CiteScore / Ranks: 3827
6.00
JIF / Ranks: 3327
3.1
Recent Articles
1.
Kusters J, Monshouwer R, Koopmans P, Wendling M, Brunenberg E, Kerkmeijer L, et al.
Strahlenther Onkol
. 2025 Mar;
PMID: 40080103
No abstract available.
2.
Liu S, Li M, Guo Z, Chen Z
Strahlenther Onkol
. 2025 Mar;
PMID: 40067453
Radiotherapy for cancer is a local treatment method that uses radiation to treat tumors. It is one of the main approaches for treating malignant tumors. Radiotherapy uses ionizing radiation on...
3.
Hintelmann K, Wahaj S, Henze M, Laakmann E, Muller V, Krug D, et al.
Strahlenther Onkol
. 2025 Mar;
PMID: 40053136
Purpose: The initial brain metastasis velocity (iBMV) is a prognostic metric introduced for patients receiving stereotactic radiosurgery (SRS) for brain metastases (BM), reflecting intracranial disease dynamics. This study aimed to...
4.
Dapper H, Rudroff C, Linde P, Rosenbrock J, Schmitz J, Ferdinandus S, et al.
Strahlenther Onkol
. 2025 Mar;
PMID: 40053135
Background: High-grade squamous intraepithelial lesions (HSIL) of the anal region are recognized as precursor lesions to squamous cell carcinoma of the anus (SCCA), especially in individuals infected with the human...
5.
Oertel M, Zielonka V, Busch U, Haverkamp U, Trommer M, Besserer A, et al.
Strahlenther Onkol
. 2025 Mar;
PMID: 40053134
Purpose: The early history of radiation and radiation oncology is imprinted by innovative pioneers both in physics and clinical application. Despite the remarkable example of Marie Curie, the contributions of...
6.
Treatment of non-small cell lung cancer: advances following the introduction of PET-CT and IMRT/VMAT
Muster J, Alt N, Edelmann M, Anczykowski M, Zwerenz C, Schirmer M, et al.
Strahlenther Onkol
. 2025 Mar;
PMID: 40050448
Purpose: In definitive radiotherapy/radiochemotherapy (RT/RCT) for localized non-small cell lung cancer (NSCLC), the introduction of positron-emission tomography (PET)-CT-based staging/RT planning and dynamic RT techniques (intensity-modulated radiotherapy, IMRT/volumetric modulated arc therapy,...
7.
Dinapoli L, Dinapoli N, Marconi E, Chiesa S, Mazzarella C, Massaccesi M, et al.
Strahlenther Onkol
. 2025 Mar;
PMID: 40047896
Purpose: Recent studies indicate that gender plays a role in influencing the side effects and outcomes of radiotherapy (RT), thus highlighting the importance of gender-specific clinical approaches. However, there remains...
8.
Trommer S, Muller J, Oertel M, Ehret F, Roohani S, Ha H, et al.
Strahlenther Onkol
. 2025 Mar;
PMID: 40029351
Background: Progression-free (PFS) and overall survival (OS) in UICC stage III non-small cell lung cancer (NSCLC) after definitive concurrent chemoradiotherapy (CRT) can be increased with consolidating immunotherapy. Recent studies have...
9.
Onal C, Guler O, Demirhan B, Erpolat P, Elmali A, Yavuz M
Strahlenther Onkol
. 2025 Feb;
PMID: 40021524
Purpose: This study aimed to investigate the effects of dose escalation through focal boost (FB) to intraprostatic lesions (IPLs) as well as the role of gallium-68 prostate-specific membrane antigen positron-emission...
10.
Roohani S, Krcek R, Reichardt P
Strahlenther Onkol
. 2025 Feb;
PMID: 40019495
No abstract available.